Elevation Oncology (ELEV) Institutional Ownership → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free ELEV Stock Alerts $3.50 -0.18 (-4.89%) (As of 01:33 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Elevation Oncology (NASDAQ:ELEV)CurrentInstitutional OwnershipPercentage83.70%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$52.49MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$7.53M Get ELEV Insider Trade Alerts Want to know when executives and insiders are buying or selling Elevation Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELEV Institutional Buying and Selling by Quarter Ad Augury ResearchBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd).Get all the details here. Elevation Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/24/2024 Farallon Capital Management LLC3,886,663$19.94M0.1%N/A7.113% 5/17/2024 Artal Group S.A.1,513,015$7.76M0.2%N/A2.769% 5/17/2024 Ikarian Capital LLC148,089$760K0.1%-87.4%0.271% 5/15/2024 venBio Partners LLC2,696,133$13.83M4.9%-7.5%4.934% 5/15/2024 Darwin Global Management Ltd.2,332,928$11.97M1.6%N/A4.270% 5/15/2024 Affinity Asset Advisors LLC1,268,825$6.51M0.8%N/A2.322% Get the Latest News and Ratings for ELEV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elevation Oncology and its competitors with MarketBeat's FREE daily newsletter. 5/10/2024 Vanguard Group Inc.1,532,045$7.86M0.0%+30.8%2.804% 5/7/2024 SG Americas Securities LLC12,244$63K0.0%N/A0.022% 11/15/2023 Armistice Capital LLC750,000$497K0.0%-68.7%1.768% 8/15/2023 Sphera Funds Management LTD.900,000$1.37M0.2%N/A2.124% 8/15/2023 Caxton Corp21,725$33K0.1%-68.2%0.051% 8/11/2023 Velan Capital Investment Management LP497,299$756K0.7%N/A1.173% 8/11/2023 ExodusPoint Capital Management LP1,499,319$2.28M0.0%N/A6.160% 5/15/2023 Sio Capital Management LLC876,611$1.67M0.8%+143.7%3.685% 5/1/2023 Virtu Financial LLC27,286$52K0.0%N/A0.115% 2/15/2023 Tang Capital Management LLC479,854$456K0.1%N/A2.059% 2/13/2023 BML Capital Management LLC39,963$38K0.0%N/A0.172% 11/14/2022 Annandale Capital LLC30,000$34K0.0%N/A0.129% 11/14/2022 Cormorant Asset Management LP1,952,032$2.21M0.2%-1.6%8.377% 8/16/2022 venBio Partners LLC1,866,339$2.61M0.7%-28.4%8.013% 8/10/2022 Kennedy Capital Management Inc.149,893$210K0.0%+968.4%0.644% 4/26/2022 Marquette Asset Management LLC38,951$98K0.0%+332.5%0.168% 4/25/2022 Bailard Inc.23,500$59K0.0%N/A0.101% 2/18/2022 TCG Crossover Management LLC555,000$3.34M1.6%N/A2.389% 2/15/2022 Kennedy Capital Management Inc.15,485$93K0.0%N/A0.067% 2/14/2022 Boxer Capital LLC872,780$5.25M0.2%-34.9%3.758% 2/14/2022 Sio Capital Management LLC250,000$1.51M0.5%N/A1.076% 1/19/2022 Marquette Asset Management LLC9,006$54K0.0%N/A0.039% 11/16/2021 Schonfeld Strategic Advisors LLC18,044$141K0.0%-29.8%0.078% 11/16/2021 Janus Henderson Group PLC1,220,205$9.38M0.0%+18.3%5.254% 11/16/2021 Caxton Corp48,183$375K0.3%+21.7%0.207% 11/9/2021 BlackRock Inc.23,837$186K0.0%N/A0.103% 8/17/2021 Weiss Multi Strategy Advisers LLC15,037$204K0.0%N/A0.066% 8/17/2021 Woodline Partners LP112,431$1.53M0.0%N/A0.493% 8/17/2021 Samsara BioCapital LLC932,239$12.65M1.6%N/A4.085% 8/17/2021 Sphera Funds Management LTD.30,000$407K0.0%N/A0.131% 8/17/2021 Millennium Management LLC123,062$1.67M0.0%N/A0.539% 8/17/2021 BVF Inc. IL1,590,291$21.58M0.8%N/A6.968% 8/17/2021 Boxer Capital LLC1,341,530$18.21M0.6%N/A5.878% 8/17/2021 Caas Capital Management LP60,000$814K0.0%N/A0.263% Collapse of the Petrodollar (Ad)The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.In answer to this issue, we have released a Special Report to the public.8/17/2021 Caxton Corp39,586$537K0.4%N/A0.173% 8/16/2021 LMR Partners LLP31,300$425K0.0%N/A0.137% 8/16/2021 Point72 Asset Management L.P.50,000$679K0.0%N/A0.219% 8/16/2021 venBio Partners LLC2,608,167$35.39M4.2%N/A11.428% 8/16/2021 Alyeska Investment Group L.P.125,000$1.70M0.0%N/A0.548% 8/16/2021 Schonfeld Strategic Advisors LLC25,700$349K0.0%N/A0.113% 8/16/2021Pinz Capital Management LP36,400$494K0.1%N/A0.159% 8/16/2021 Maven Securities LTD16,000$204K0.0%N/A0.070% 8/16/2021 Goldman Sachs Group Inc.62,500$848K0.0%N/A0.274% 8/13/2021 Northern Trust Corp4,803$65K0.0%N/A0.021% 8/13/2021 Qube Research & Technologies Ltd24,255$329K0.0%N/A0.106% 8/13/2021 Vanguard Group Inc.60,000$814K0.0%N/A0.263% 8/12/2021 Monashee Investment Management LLC140,000$1.90M0.2%N/A0.613% 8/11/2021 Ghost Tree Capital LLC100,000$1.36M0.4%N/A0.438% (Data available from 1/1/2016 forward) ELEV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELEV shares? During the previous two years, 20 institutional investors and hedge funds held shares of Elevation Oncology. The most heavily invested institutionals were Farallon Capital Management LLC ($19.94M), venBio Partners LLC ($13.83M), Darwin Global Management Ltd. ($11.97M), Vanguard Group Inc. ($7.86M), Artal Group S.A. ($7.76M), Affinity Asset Advisors LLC ($6.51M), and ExodusPoint Capital Management LP ($2.28M).Learn more on ELEV's institutional investors. What percentage of Elevation Oncology stock is owned by institutional investors? 83.70% of Elevation Oncology stock is owned by institutional investors. Learn more on ELEV's institutional investor holdings. Which institutional investors have been buying Elevation Oncology stock? Of the 15 institutional investors that purchased Elevation Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Farallon Capital Management LLC ($3.89M), Darwin Global Management Ltd. ($2.33M), Artal Group S.A. ($1.51M), ExodusPoint Capital Management LP ($1.50M), Affinity Asset Advisors LLC ($1.27M), Sphera Funds Management LTD. ($900K), and Sio Capital Management LLC ($516.88K). How much institutional buying is happening at Elevation Oncology? Institutional investors have bought a total of 13,500,938 shares in the last 24 months. This purchase volume represents approximately $54.25M in transactions. Which Elevation Oncology major shareholders have been selling company stock? The following institutional investors have sold Elevation Oncology stock in the last 24 months: Armistice Capital LLC ($1.65M), Ikarian Capital LLC ($1.02M), venBio Partners LLC ($959.95K), Caxton Corp ($46.60K), and Cormorant Asset Management LP ($31.14K). How much institutional selling is happening at Elevation Oncology? Institutional investors have sold a total of 3,707,535 shares in the last 24 months. This volume of shares sold represents approximately $8.61M in transactions. Related Companies: RAIN Major Shareholders INKT Major Shareholders BOLT Major Shareholders INBX Major Shareholders RLAY Major Shareholders MESO Major Shareholders PROK Major Shareholders PRME Major Shareholders SRRK Major Shareholders CRGX Major Shareholders This page (NASDAQ:ELEV) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevation Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevation Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.